The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A single-arm, open-label, phase I study of CPI-613 (Devimistat) in combination with gemcitabine and nab-paclitaxel for patients with locally advanced or metastatic pancreatic adenocarcinoma.
 
Angela Tatiana Alistar
Consulting or Advisory Role - Rafael Pharmaceuticals
Speakers' Bureau - Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Rafael Pharmaceuticals
 
Bonny Morris
No Relationships to Disclose
 
Lawrence Harrison
No Relationships to Disclose
 
Kai Bickenbach
No Relationships to Disclose
 
Lee Starker
No Relationships to Disclose
 
Nancy Ginder
No Relationships to Disclose
 
Laura McIlwain
No Relationships to Disclose
 
Sanjeev Luther
Employment - Rafael Pharmaceuticals
Leadership - Rafael Pharmaceuticals
Stock and Other Ownership Interests - Rafael Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Pending
Travel, Accommodations, Expenses - Rafael Pharmaceuticals
 
Timothy S. Pardee
Employment - Rafael Pharmaceuticals
Leadership - Rafael Pharmaceuticals
Honoraria - CBM Biopharma
Consulting or Advisory Role - CBM Biopharma
Speakers' Bureau - Amgen; Celgene; Novartis; Pharmacyclics
Research Funding - Rafael Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Named on a provisional patent on the use of KPC34 for the treatment of acute leukemias.
Travel, Accommodations, Expenses - Pharmacyclics; Rafael Pharmaceuticals
 
Justin Alpert
No Relationships to Disclose